Prothena Corporation PLC (NASDAQ:PRTA)
| 13.30 Data as of 10:32am ET |  +0.53 / +4.15%Today’s Change | 5.64 Today|||52-Week Range 13.84 | +81.45% Year-to-Date |
Latest PRTA News | Press Releases
No recent news for Prothena Corporation PLC.
Today’s Trading
| Previous close | 12.77 |
| Today’s open | 12.82 |
| Day’s range | 12.56 - 13.84 |
| Volume | 33,683 |
| Average volume (3 months) | 54,204 |
| Market cap | $225.8M |
| Dividend yield | -- |
Data as of 10:32am ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -68.69% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +431.60% |
| P/E ratio | -- |
| Price/Sales | 40.24 |
| Price/Book | 1.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRTXCornerstone Therapeu... | +0.04 | +0.47% |
| SVASinovac Biotech Ltd | +0.01 | +0.25% |
| INSYInsys Therapeutics I... | +0.02 | +0.18% |
| --Genufood Energy Enzy... | 0.00 | 0.00% |
Data as of 10:36am ET, 06/19/2013
Financials
| Next reporting date | August 28, 2013 |
| EPS forecast (this quarter) | -$0.54 |
| Annual revenue (last year) | $2.7M |
| Annual profit (last year) | -$41.4M |
| Net profit margin | -1,557.98% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Dale B. Schenk, PhD |
Chief Financial Officer & Head-Investor Relations Tran B. Nguyen, MBA |
Corporate headquarters Dublin, Dublin |
Forecasts
